Long-Term Investments (Details) - USD ($) |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
Dec. 31, 2022 |
|
| Long-Term Investments [Line Items] | ||||
| Percentage of ordinary shares | 37.00% | |||
| Prepayment for long-term investment | $ 1,789,703 | $ 1,124,842 | ||
| Disposition of long-term investment | ||||
| Purchase additional shares (in Shares) | 136,000 | |||
| Aggregate amount | $ 680,000 | |||
| Canal biotech corporation [Member] | ||||
| Long-Term Investments [Line Items] | ||||
| Ownership percentage | 0.39% | |||
| BioFirst Corporation [Member] | ||||
| Long-Term Investments [Line Items] | ||||
| Ownership percentage | 18.68% | 18.68% | ||
| Percentage of ordinary shares | 18.68% | 18.68% | ||
| Aggregate amount | $ 2,688,578 | |||
| Prepayment amount | $ 1,895,556 | |||
| Converted shares (in Shares) | 994,450 | |||
| Prepayment for long-term investment | $ 1,124,842 | $ 1,124,842 | ||
| Rgene Corporation (the “Rgene”) [Member] | ||||
| Long-Term Investments [Line Items] | ||||
| Percentage of ordinary shares | 26.65% | |||
| X | ||||||||||
- Definition The amount of aggregate amount. No definition available.
|
| X | ||||||||||
- Definition Percentage value of common stocks shares. No definition available.
|
| X | ||||||||||
- Definition The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The net amount paid (received) by the reporting entity through acquisition or sale and maturities of long-term investments which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term. No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income earned, after hedging basis adjustments, from fees charged for prepayment of certain Federal Home Loan Bank (FHLBank) advances before original maturity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|